Antibiotic drug Nitrofurantoin (AMCo, Morningside Healthcare, Morningside Pharmaceuticals and Alliance Healthcare) (50507)

The following Competition practice note provides comprehensive and up to date legal information covering:

  • Antibiotic drug Nitrofurantoin (AMCo, Morningside Healthcare, Morningside Pharmaceuticals and Alliance Healthcare) (50507)
  • Case facts
  • Timeline
  • Commentary
  • Related cases

Antibiotic drug Nitrofurantoin (AMCo, Morningside Healthcare, Morningside Pharmaceuticals and Alliance Healthcare) (50507)

CASE HUB

See further, timeline ,commentary and related cases.

Case facts

OutlineCMA Article 101 TFEU/Chapter I investigation into AMCo (now Advanz Pharma Services (UK) Limited), Morningside Healthcare Limited, Morningside Pharmaceuticals Limited and Alliance Healthcare (Distribution) Limited in relation to an alleged breach of competition law concerning the supply of the antibiotic drug Nitrofurantoin.

Latest developmentsOn 25 July 2019, the CMA issued a statement of objections to AMCo (now Advanz Pharma Services (UK) Limited), Morningside Healthcare Limited, Morningside Pharmaceuticals Limited and Alliance Healthcare (Distribution) Limited.

Parties• Advanz Pharma Services (UK) Limited (Advanz): Advanz is a wholly-owned subsidiary of Mercury Pharma Group Limited, which is incorporated in the UK. It is principally engaged in the provision of support services on behalf of the group headed by Concordia International Corp. (formerly Concordia Healthcare Corp).

• Mercury Pharma Group Limited (Mercury): Mercury is a wholly-owned subsidiary of Concordia Holdings (UK) Limited and is an intermediate holding company. The principal activity of Mercury is that of a holding company of the operating and group services businesses and providing licensing of product rights.

• Cinven Capital Management (CCM): The principal activity of CCM is to act as an intermediate holding company. CCM’s ultimate parent entity is Cinven Partners LLP.

• General Partner Limited (GPL): GPL is part of Cinven
Discover LexisPSL
Clear, practical guidance for all legal professionals
Related documents:

Popular documents

Multilateral Trading Facilities (MTFs)

Multilateral Trading Facilities (MTFs)

Multilateral Trading Facilities (MTFs)BREXIT: 11pm (GMT) on 31 December 2020 (‘IP completion day’) marked the end of the Brexit transition/implementation period entered into following the UK’s withdrawal from the EU. Following IP completion day, key transitional arrangements come to an end and

Reversionary lease by reference

Reversionary lease by reference

 LR1. Date of the lease[date]LR2. Title Number(s)LR2.1 Landlord's title number(s)[title numbers out of which this Lease is granted. Leave blank if not registered]LR2.2 Other title numbers[existing title number(s) against which entries of matters referred to in LR9, LR10, LR11 and LR13 are to be

Indemnity costs orders—principles

Indemnity costs orders—principles

Indemnity costs orders—principlesThis Practice Note considers orders for costs determined on an indemnity basis (indemnity costs orders). A court may order that costs are assessed on an indemnity basis so that any doubt as to the costs claimed are resolved in favour of the receiving party. Compare

Qualified one-way costs shifting (QOCS)

Qualified one-way costs shifting (QOCS)

Qualified one-way costs shifting (QOCS)What is QOCS?Qualified one-way costs shifting (QOCS) was introduced on 1 April 2013 as part of the Jackson costs reforms following the removal of a claimant’s right to recover additional liabilities from the defendant, ie success fees and after the event (ATE)